Please login to the form below

Not currently logged in


This page shows the latest Palovarotene news and features for those working in and with pharma, biotech and healthcare.

Ipsen’s Sohonos approved by Health Canada

Ipsen’s Sohonos approved by Health Canada

Ipsen has announced the approval of its drug Sohonos (palovarotene) for the treatment of the ultra-rare genetic disorder fibrodysplasia ossificans progressiva (FOP), issued by Health Canada, marking the first global ... Ipsen had previously announced the

Latest news

  • Revenue growth at Ipsen numbs pain of palovarotene calamity Revenue growth at Ipsen numbs pain of palovarotene calamity

    It hopes to “define next steps for the clinical programme to bring palovarotene to patients as quickly as possible”, according to its annual results statement. ... In the near-term, Ipsen’s late-stage R&D beyond palovarotene is focused mainly on

  • Ipsen buys rare disease group Clementia in $1.3bn deal Ipsen buys rare disease group Clementia in $1.3bn deal

    Ipsen could enter a potentially lucrative market with palovarotene for both FOP and MO, for which there are no current treatments approved for these types of diseases. ... possible. “We anticipate a smooth transition of our operations into the Ipsen

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

Environment: where does the pharmaceutical industry stand?
The communication challenge of helping he next generation to be healthier
As the pressure on the health service increases the health of the next generation is vital for everyone. How do we show positive attitudes and change behaviour while future proofing...
Are we losing sight of what the democratisation of healthcare really looks like?
We have a core responsibility as healthcare communicators to consistently drive for better inclusion, engagement and compliance. What does the ‘democratisation of healthcare’ really look like?...